Japan’s Genesia Ventures has completed the final close of its fourth fund at $113 million, with the capital earmarked for seed-stage startups across Japan, Southeast Asia, and India.

In a statement on Wednesday, Genesia Ventures said Fund IV is backed primarily by domestic and international institutional investors and financial institutions. The firm said it plans to be more selective in the number of investments made compared to previous funds, concentrating capital more deeply in each portfolio company.

Genesia Ventures operates through offices in Tokyo, Jakarta, Ho Chi Minh City, and Bengaluru. The firm does not define its investment strategy by fixed industry sectors, instead focusing on underlying drivers of structural change. Its portfolio spans sectors including healthcare, insurance, renewable energy, supply chain infrastructure, alternative credit, space transportation, battery intelligence, and advanced materials.

Soichi Tajima, Founder and General Partner, said the firm would be more selective in the number of investments made while investing more deeply in each company. “We will continue backing founders operating at the intersection of transformational changes and pursuing opportunities with the potential to create significant societal impact,” he said.

Takahiro Suzuki, Head of Overseas Investments and General Partner, said advances in AI, energy transition, and Asia’s economic rise were removing long-standing barriers to industrial progress at unprecedented speed. “I strongly believe this is an era in which startups have expanding opportunities to create major businesses and industries,” he said.

Vietnam focus

Vietnam remains one of Genesia Ventures’ key strategic markets in Southeast Asia. The firm has backed several Vietnam-based startups, including Buymed, a pharmaceutical distribution infrastructure company; KAMEREO, a food procurement infrastructure platform; and Fundiin, an alternative credit infrastructure company.

The firm has also developed Genesia Orbit Vietnam, a founder growth platform offering workshops, knowledge-sharing programmes, and cross-border community activities for early-stage entrepreneurs in the country.

Selected exits

Among the firm’s notable exits, Timee completed its IPO on the Tokyo Stock Exchange Growth Market in July 2024, while HRBrain completed a secondary exit to European investment fund EQT in November 2023. Southeast Asian portfolio companies include Docquity, a doctor platform operating across seven countries, and Qoala, an insurance solutions platform operating across five countries.

Malaysia’s AI, smart mobility firms secure $115M export pipeline in Japan